Versant Ventures VII GP, L.P. - 26 Oct 2026 Form 4 Insider Report for Lycia Therapeutics, Inc. (LYCA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 Oct 2026, 17:28:11 UTC
Prior SEC filing
22 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Filing notes and source

Key filing fact

Versant Ventures VII GP, L.P. filed Form 4 for Lycia Therapeutics, Inc. (LYCA) on 28 Oct 2026.

Key facts

  • This page summarizes Versant Ventures VII GP, L.P.'s Form 4 filing for Lycia Therapeutics, Inc. (LYCA).
  • 4 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 28 Oct 2026, 17:28.

Change

  • Previous filing in this sequence was filed on 22 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (6)

CIK 0001777655 Primary reporting owner

Versant Ventures VII GP, L.P.

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Venture Capital VII, L.P. By: Versant Ventures VII GP, L.P. Its: General Partner By: Versant Ventures VII GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026
CIK 0001750266

Versant Venture Capital VII, L.P.

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Ventures VII GP, L.P., By: Versant Ventures VII GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026
CIK 0001777656

Versant Ventures VII GP-GP, LLC

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Ventures VII GP-GP, LLC By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026
CIK 0001832235

Versant Vantage II, L.P.

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Vantage II, LP By: Versant Vantage II GP, L.P. Its: General Partner By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026
CIK 0001839790

Versant Vantage II GP, L.P.

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Vantage II GP, L.P., By: Versant Vantage II GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026
CIK 0001839789

Versant Vantage II GP-GP, LLC

Relationship
10%+ Owner
Address
ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO
Signature
Versant Vantage II GP-GP, LLC, By: /s/ Max Eisenberg Its: Chief Operating Officer
Signature date
28 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+5,631,425
Change %
Price
Shares after
5,631,425
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F2
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3
LYCA transaction

Common Stock

Conversion of derivative security

Transaction value
Shares
+1,393,882
Change %
Price
Shares after
1,393,882
Date
26 Oct 2026
Ownership
See Footnote
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series A Preferred Stock

Conversion of derivative security

Transaction value
Shares
-25,390,410
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
5,631,425
Exercise price
Footnotes
F1, F2
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
LYCA transaction Derivative

Series B Preferred Stock

Conversion of derivative security

Transaction value
Shares
-6,284,597
Change %
-100%
Price
Shares after
0
Date
26 Oct 2026
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
1,393,882
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a one-for-0.221793422 basis upon the closing of the Issuer's initial public offering on October 26, 2026, without payment of consideration. The Series A Preferred Stock and Series B Preferred Stock have no expiration date.

Footnote F2

The shares are held directly by Versant Venture Capital VII, L.P. ("VVC VII"). Versant Ventures VII GP, L.P. ("VV VII GP") is the general partner of VVC VII, and Versant Ventures VII GP-GP, LLC ("VV VII GP-GP") is the general partner of VV VII GP. Each of VV VII GP-GP and VV VII GP disclaims beneficial ownership of the shares held by VVC VII, except to the extent of their respective pecuniary interests therein.

Footnote F3

The shares are held directly by Versant Vantage II, L.P. ("VV II"). Versant Vantage II GP, L.P. ("VV II GP") is the general partner of VV II, and Versant Vantage II GP-GP, LLC ("VV II GP-GP") is the general partner of VV II GP. Each of VV II GP-GP and VV II GP disclaims beneficial ownership of the shares held by VV II, except to the extent of their respective pecuniary interests therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .